VITALHUB CORP (VHI.CA) Stock Fundamental Analysis
Canada - TSX:VHI - CA92847V5018 - Common Stock
8.97 CAD
+0.12 (+1.36%)
Taking everything into account, VHI scores 6 out of 10 in our fundamental rating. VHI was compared to 8 industry peers in the Health Care Technology industry. VHI scores excellent points on both the profitability and health parts. This is a solid base for a good stock. VHI is growing strongly while it is still valued neutral. This is a good combination! These ratings would make VHI suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year VHI was profitable.
In the past year VHI had a positive cash flow from operations.
In multiple years VHI reported negative net income over the last 5 years.
Of the past 5 years VHI 4 years had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 0.76%, VHI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Return On Equity of VHI (1.08%) is better than 100.00% of its industry peers.
The Return On Invested Capital of VHI (2.86%) is better than 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for VHI is in line with the industry average of 2.86%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 1.08% | ||
| ROIC | 2.86% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 2.88%, VHI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
VHI has a better Operating Margin (12.47%) than 100.00% of its industry peers.
VHI's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 80.92%, VHI belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
VHI's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.47% | ||
| PM (TTM) | 2.88% | ||
| GM | 80.92% |
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VHI is destroying value.
VHI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, VHI has more shares outstanding
VHI has a better debt/assets ratio than last year.
2.2 Solvency
VHI has an Altman-Z score of 3.78. This indicates that VHI is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.78, VHI is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
VHI has a debt to FCF ratio of 0.13. This is a very positive value and a sign of high solvency as it would only need 0.13 years to pay back of all of its debts.
VHI's Debt to FCF ratio of 0.13 is amongst the best of the industry. VHI outperforms 87.50% of its industry peers.
VHI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
VHI's Debt to Equity ratio of 0.00 is fine compared to the rest of the industry. VHI outperforms 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.13 | ||
| Altman-Z | 3.78 |
ROIC/WACC0.29
WACC9.77%
2.3 Liquidity
VHI has a Current Ratio of 1.94. This is a normal value and indicates that VHI is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of VHI (1.94) is better than 87.50% of its industry peers.
A Quick Ratio of 1.94 indicates that VHI should not have too much problems paying its short term obligations.
VHI's Quick ratio of 1.94 is amongst the best of the industry. VHI outperforms 87.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 |
3. Growth
3.1 Past
The earnings per share for VHI have decreased strongly by -36.36% in the last year.
Looking at the last year, VHI shows a very strong growth in Revenue. The Revenue has grown by 59.34%.
VHI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 46.32% yearly.
EPS 1Y (TTM)-36.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-163.4%
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%
3.2 Future
VHI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 82.03% yearly.
The Revenue is expected to grow by 27.30% on average over the next years. This is a very strong growth
EPS Next Y68.34%
EPS Next 2Y107.36%
EPS Next 3Y82.03%
EPS Next 5YN/A
Revenue Next Year53.3%
Revenue Next 2Y36.21%
Revenue Next 3Y27.3%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 128.14 indicates a quite expensive valuation of VHI.
100.00% of the companies in the same industry are more expensive than VHI, based on the Price/Earnings ratio.
VHI is valuated expensively when we compare the Price/Earnings ratio to 25.46, which is the current average of the S&P500 Index.
VHI is valuated quite expensively with a Price/Forward Earnings ratio of 29.80.
87.50% of the companies in the same industry are more expensive than VHI, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of VHI to the average of the S&P500 Index (35.39), we can say VHI is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 128.14 | ||
| Fwd PE | 29.8 |
4.2 Price Multiples
100.00% of the companies in the same industry are more expensive than VHI, based on the Enterprise Value to EBITDA ratio.
VHI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. VHI is cheaper than 87.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 46.38 | ||
| EV/EBITDA | 20.29 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of VHI may justify a higher PE ratio.
A more expensive valuation may be justified as VHI's earnings are expected to grow with 82.03% in the coming years.
PEG (NY)1.88
PEG (5Y)N/A
EPS Next 2Y107.36%
EPS Next 3Y82.03%
5. Dividend
5.1 Amount
VHI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:VHI (11/18/2025, 7:00:00 PM)
8.97
+0.12 (+1.36%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners28.48%
Inst Owner ChangeN/A
Ins Owners11.46%
Ins Owner ChangeN/A
Market Cap565.11M
Revenue(TTM)98.17M
Net Income(TTM)2.83M
Analysts81.33
Price Target15.74 (75.47%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)9.95%
Min Revenue beat(2)7.24%
Max Revenue beat(2)12.66%
Revenue beat(4)4
Avg Revenue beat(4)6.3%
Min Revenue beat(4)0.61%
Max Revenue beat(4)12.66%
Revenue beat(8)6
Avg Revenue beat(8)4.15%
Revenue beat(12)10
Avg Revenue beat(12)4.05%
Revenue beat(16)12
Avg Revenue beat(16)4.16%
PT rev (1m)-0.28%
PT rev (3m)5.02%
EPS NQ rev (1m)-7.64%
EPS NQ rev (3m)-10.93%
EPS NY rev (1m)0.36%
EPS NY rev (3m)-46.62%
Revenue NQ rev (1m)0.36%
Revenue NQ rev (3m)5.06%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)4.49%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 128.14 | ||
| Fwd PE | 29.8 | ||
| P/S | 5.76 | ||
| P/FCF | 46.38 | ||
| P/OCF | 43.74 | ||
| P/B | 2.16 | ||
| P/tB | 11.48 | ||
| EV/EBITDA | 20.29 |
EPS(TTM)0.07
EY0.78%
EPS(NY)0.3
Fwd EY3.36%
FCF(TTM)0.19
FCFY2.16%
OCF(TTM)0.21
OCFY2.29%
SpS1.56
BVpS4.16
TBVpS0.78
PEG (NY)1.88
PEG (5Y)N/A
Graham Number2.56
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 1.08% | ||
| ROCE | 4.19% | ||
| ROIC | 2.86% | ||
| ROICexc | 4.95% | ||
| ROICexgc | N/A | ||
| OM | 12.47% | ||
| PM (TTM) | 2.88% | ||
| GM | 80.92% | ||
| FCFM | 12.41% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
ROICexc(3y)5.88%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y132.1%
ROICexc growth 5YN/A
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
F-Score3
Asset Turnover0.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.13 | ||
| Debt/EBITDA | 0.05 | ||
| Cap/Depr | 7.67% | ||
| Cap/Sales | 0.75% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 59.17% | ||
| Profit Quality | 430.43% | ||
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 | ||
| Altman-Z | 3.78 |
F-Score3
WACC9.77%
ROIC/WACC0.29
Cap/Depr(3y)9.42%
Cap/Depr(5y)8.61%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.89%
Profit Quality(3y)466.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-163.4%
EPS Next Y68.34%
EPS Next 2Y107.36%
EPS Next 3Y82.03%
EPS Next 5YN/A
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%
Revenue Next Year53.3%
Revenue Next 2Y36.21%
Revenue Next 3Y27.3%
Revenue Next 5YN/A
EBIT growth 1Y46.83%
EBIT growth 3Y217.15%
EBIT growth 5YN/A
EBIT Next Year69.12%
EBIT Next 3Y40.69%
EBIT Next 5YN/A
FCF growth 1Y-12.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.32%
OCF growth 3YN/A
OCF growth 5YN/A
VITALHUB CORP / VHI.CA FAQ
What is the fundamental rating for VHI stock?
ChartMill assigns a fundamental rating of 6 / 10 to VHI.CA.
Can you provide the valuation status for VITALHUB CORP?
ChartMill assigns a valuation rating of 6 / 10 to VITALHUB CORP (VHI.CA). This can be considered as Fairly Valued.
Can you provide the profitability details for VITALHUB CORP?
VITALHUB CORP (VHI.CA) has a profitability rating of 7 / 10.
What are the PE and PB ratios of VITALHUB CORP (VHI.CA) stock?
The Price/Earnings (PE) ratio for VITALHUB CORP (VHI.CA) is 128.14 and the Price/Book (PB) ratio is 2.16.